M. Haven

Comparison of the antisecretory effects of omeprazole when administered intravenously, as acid-stable granules and as an oral paste in horses.

G. Hickey, M. Haven, K. Dave, 2010, Equine veterinary journal. Supplement.

Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses.

G. Hickey, G. Hickey, M. Murray, 1997, Equine veterinary journal.

5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure-activity relationship studies of 5-alkylethers and 5-thioethers.

M. P. Lynch, S. Sakya, Jin Li, 2006, Bioorganic & medicinal chemistry letters.

5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog.

M. P. Lynch, S. Sakya, Jin Li, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.

S. Sakya, Jin Li, Hengmiao Cheng, 2006, Bioorganic & medicinal chemistry letters.

5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile.

S. Sakya, Jin Li, Xinjun Hou, 2007, Bioorganic & medicinal chemistry letters.

Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization

R. Lieber, Michael A. Lopez, R. Nargund, 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition.

M. P. Lynch, S. Sakya, Jin Li, 2008, Bioorganic & medicinal chemistry letters.

Leiomyoma of the small colon in a horse.

K. Bowman, J. Rottman, M. Haven, 1991, Veterinary surgery : VS.

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.

M. P. Lynch, S. Sakya, Jin Li, 2004, Bioorganic & medicinal chemistry letters.

In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor.

M. P. Lynch, S. Sakya, Jin Li, 2005, Bioorganic & medicinal chemistry.